Category: ANNOUNCEMENTS - Page 14 - Start Medical Product Development

BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE™ Scaffold in Breast Implant Revision Surgery

March 20, 2025

FRANKLIN LAKES, N.J., March 20, 2025 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the first patient treated in an Investigational Device Exemption (IDE) clinical trial intended to advance BD’s efforts to achieve Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for the use of GalaFLEX LITE™ Scaffold in decreasing capsular contracture (CC) recurrence during breast revision surgery.

Medtronic reports first real-world data on smart insulin pen system

March 20, 2025

Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.

Tandem Diabetes Care introduces next-gen automated insulin delivery algorithm

March 18, 2025

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in the U.S.

Bausch + Lomb launches intelligent lens-fitting system

March 17, 2025

Bausch + Lomb announced today that it launched Arise, its intelligent, cloud-based lens-fitting system, in the U.S.

Vivani reports first human GLP-1 implant for weight loss in adults

March 13, 2025

Vivani Medical (Nasdaq:VANI) announced today that it successfully administered the first GLP-1 implant in its LIBERATE-1 clinical trial.

Think Surgical announces first TMINI robotic procedures using LinkSymphoKnee

March 9, 2025

Think Surgical today announced the first successful use of Waldemar Link’s LinkSymphoKnee using the TMINI Miniature Robotic System.

IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense™ Cryoablation System in Israel

February 24, 2025

Application covering a wide range of indications is in line with trends in de-escalation of surgery and growth in minimally invasive cryoablation procedures, pointing to strong potential for increasing demand

Islet transplantation with blood vessel cells shows promise to treat type 1 diabetes

February 21, 2025

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine investigators. The new approach, which requires further development and testing, could someday enable the much wider use of islet transplants to cure diabetes.

CathVision Receives CE Mark for ECGenius System, Advancing Cardiac Monitoring and Analytics Technology in Europe

February 19, 2025

COPENHAGEN, Denmark, Feb. 19, 2025 /PRNewswire/ — CathVision, a medical technology company developing advanced electrophysiology solutions, is proud to announce that it has received CE Mark for its breakthrough product, ECGenius System. This regulatory milestone allows CathVision to market and distribute ECGenius System across the European Economic Area (EEA), bringing state-of-the-art electrophysiology solutions to healthcare providers and patients.

Boston Scientific wins CE mark for Farapulse Nav mapping tech

February 17, 2025

Boston Scientific (NYSE: BSX)+
announced today that it received CE mark for its navigation-enabled Farawave Nav ablation catheter and Faraview software.

Blog

- ANNOUNCEMENTS